ERBB2 and carcinoma: The four responding models belonged to two different breast carcinoma subtypes: three were basal like carcinomas (HBCx-7, HBCx-10, and HBCx-19) and one was an ERBB2-overexpressing breast carcinoma (HBCx-5).